$SBC

SBC Medical Group Holdings Inc (SBC): Submission of Matters to a Vote of Security Holders

SBC Medical Group Holdings Inc (SBC) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. EX-3.2 3 ex3-2.htm EX-3.2 Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF SBC MEDICAL GROUP HOLDINGS INCORPORATED Adopted: July 8, 2026 1. Offices . The address of the registered office of SBC Medical Group Holdings Incorporated (the “ Corporation ”) in the State of Delaware, and the

Original reporting
Published Jul 14, 2026, 9:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 14, 2026, 9:03 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$SBC
Neutral
high confidence
Mentioned
$SBC
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$SBCNeutralLow
01

Why it matters

The disclosure primarily updates corporate governance mechanics (e.g., meeting modalities, record dates, notice/waiver rules). It does not provide new financial performance, strategy, or regulatory outcomes in the excerpt.

02

Market read

Governance vote filings can affect proxy-vote dynamics, but this excerpt contains no material business or financial catalyst.

03

What to watch

Traders may want to check the full 8-K for the actual proposals submitted to shareholders, voting outcomes, and any related risk factors, which are not included in the excerpt.

Relevance 6/10Novelty 2/10Timing: as filed today on SEC EDGAR, ahead of the shareholder vote timeline

Background

The article is an SEC Form 8-K item 5.07 submission of matters to a vote of security holders, including an exhibit with amended and restated bylaws adopted July 8, 2026.

Company-level read

Ticker impact

$SBCNeutralHigh confidence
Context

SBC filed an 8-K reporting the submission of matters to a vote of security holders, with amended and restated bylaws as an exhibit.

Expected impact

Likely limited near-term impact unless the vote results in material governance changes or signals broader corporate action.

Evidence & confidence

The filing describes procedural items (submission to vote, bylaws provisions like meeting mechanics and record dates) without any new earnings, guidance, deal, or enforcement event.

Market effects

No clear sector read-through from bylaws/meeting mechanics.

None indicated.

None indicated.

Counterpoint

The vote could still matter if it enables or reflects upcoming strategic actions, but the provided text does not disclose such specifics.

Key entities

  • SBC Medical Group Holdings Inc

    Subject of the SEC 8-K, reporting matters submitted to a vote and providing amended and restated bylaws as an exhibit.

Related articles

$SBCMedAI 8/10

SBC Medical Group Re-Accelerates Growth as EBITDA Surges 32% in Q2

SBC Medical Group reported a 32% EBITDA surge in Q2, with Gorilla Clinic's transaction value up 19% YoY to $62M. The company is expanding non-aesthetic healthcare, using AI for efficiency, and pursuing M&A. It expects $15M in annual service-fee increases. SBC is also advancing U.S. and Southeast Asia expansion, with plans for a longevity center in Japan. The company has $184M in cash for growth and M&A, aiming for steady EPS growth.

$SBCMedAI 8/10

SBC Medical Group Holdings Reports Second Quarter 2026 Financial Results

SBC Medical Group Holdings (Nasdaq: SBC) reported Q2 FY2026 results for the three months ended June 30, 2026. Total revenue rose 13% to $49 million. Net income attributable to SBC Medical increased 335% to $11 million, with basic EPS of $0.10. Adjusted EBITDA rose 32% to $20 million. The company cited AI-enabled support and fee expansions, and said it has $184 million cash.

$SBCMedAI 8/10

SBC Medical Group Holdings Incorporated: SBC Medical Group Holdings Reports Second Quarter 2026 Financial Results

SBC Medical Group Holdings (Nasdaq: SBC) reported Q2 FY2026 results for the three months ended June 30, 2026. Total revenue rose 13% to $49 million. Net income attributable to SBC Medical increased 335% to $11 million, and Adjusted EBITDA rose 32% to $20 million. The company cited AI-enabled fee increases and expects about $15 million in annual service-fee gains if fully realized.

$SBCMed

SBC Medical Group Holdings Inc (SBC): Results of Operations and Financial Condition

SBC Medical Group Holdings Inc (SBC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SBC Medical Group Holdings Reports Second Quarter 2026 Financial Results Restructuring Complete, Growth Reaccelerates: Q2 Revenue Up 13%, Net Income Attributable to SBC Medical Up 335%, Adjusted EBITDA 1 Up 32% Year-over-Year. AI-Enabled Service Enhancements Drive Su

$ELVRMed

Elevra Lithium Ltd (ASX:ELV) Corporate Presentation - Outlines Growth Strategy for North American Lithium Platform

Elevra Lithium Ltd (ASX:ELV) outlined its growth strategy for North American Lithium (NAL) in Quebec, targeting 373,000 tonnes of spodumene concentrate annually. FY26 production was 197,967 tonnes, with revenue of US$202 million. The company plans a three-stage expansion, with initial capital expenditure of US$271 million. FY27 production guidance is 198,000 to 210,000 tonnes.

$CVXMedAI 8/10

Chevron (CVX) Doubles Down on Venezuela with a $7 Billion Oil Bet

Chevron (CVX) plans to invest $7 billion in Venezuela over five years to double oil production to 600,000 barrels per day, adding areas in the Orinoco Belt to its joint venture with PDVSA. The move leverages Chevron's existing presence and aims for low-cost growth, despite political and regulatory risks. Venezuela holds the world's largest crude oil reserves but faces infrastructure challenges.